Terminal Value investing: Finding Your Next Gorilla Stock

We are seeing an era of large value creation in stocks, either due to new opportunities (mega trends) or sector disruptions.  If we rewind, the largest company in US by market cap was at a $100bn market cap in 2001. It moved to $300-400bn in 2008. A decade and a half later it is much more than $1 trillion. 

Just as India celebrated surpassing Japan to become the 4th largest economy, a single US corporation surpassed our GDP in market value.

Over three decades ago, the Nikkei Bubble of 1989 saw Japan becoming a $4 trillion economy and its stock market making up 45% of the world market cap.  Companies from Sony to Toyota to Panasonic to Honda to Nissan to Hitachi surprised the world. The Indian market too is seeing value creation today, either due to new opportunities or disruptive trends. But given their rich valuations, betting on stocks with large value creation potential can be a swim-or-sink choice.

Rakesh Jhunjhunwala, the role model for Indian investors looking to net multi-baggers, favoured an investment philosophy, looking far into the future, to identify stocks with multi-bagger potential. Trust MF, led by Utpal Sheth – RJ’s right-hand man – came up with a framework based on his learnings over decades and called it Terminal Value Investing or Gorilla Investing. This article deep dives into how this philosophy works. Please note that this is not a recommendation to invest in Trust MF schemes.

What is terminal value?

The value of a company is the present value of all its future cash flows. This is the basic principle which underlies the Discounted Cash Flow Method of valuation or the famous DCF.

In DCF, there are two components.

  • The present value of all cash flows for the forecast period.
  • Terminal value or residual value of a business beyond this period.

But here’s the catch. 

There’s always a limit to which the future cash flows of a business can be forecasted – say 10 years or 15 years into the future. This is because variables such as growth, cost of capital, capex, working capital etc which are unpredictable beyond a point. But the life of a good company is far beyond that, often stretching into decades. During the life of a company, there can be acquisitions or capital allocation decisions that can change its trajectory.

Imagine that you did a DCF model of Mahindra & Mahindra or Larsen & Toubro or Marico 10 or 15 years ago.  You may have forecast cash flows for 10 years and then assumed that they would grow at 4-5% for their remaining life (residual life). This is their “terminal value”.

But can you see how off-the-mark the 4-5% growth assumption was? These companies are still very robust and growing, perhaps at higher rates than in the past. Marico was a single product business (Parachute) 15 years ago and today it has multiple brands, while building out a D2C portfolio from scratch.  M&M has delivered an unusual success story in the Indian auto industry. For Larsen & Toubro, over a third of its valuation now comes from its IT subsidiaries with a far better cash flow profile than its legacy business.

So, one would have gone terribly wrong in using the standard DCF assumptions for such companies, if we had arrived at a terminal value based on 4-5% long-term growth assumptions. This is why getting a more accurate grip on Terminal Value is critical. 

The Terminal Value Paradox: Why Future Dreams Drive Today’s Prices

Let’s try to understand how terminal value plays a big role in valuation with the help of few popular real-life examples.

Consider this: buying Zomato today costs Rs 2.5 lakh crore, while Dixon requires Rs 1 lakh crore. Yet neither company’s Year 1 cash flows would cover even a fraction of your interest costs on such investments.

So why do investors pay these prices? Terminal value—the expectation that these businesses will dominate their markets for the next 20-25 years. Roughly 80% of Zomato’s and Dixon’s current valuations stem from cash flows expected after Year 10. Strip away these terminal value assumptions, and their stock prices would collapse to just 20% of today’s levels.

The contrast is stark. Hero MotoCorp and Wipro trade based purely on present realities: existing cash reserves plus predictable 10-year cash flows. Hero MotoCorp, with Rs 14,000 crore in cash and Rs 5,000 crore in annual cash flows, trades roughly at its 10-year DCF value. Wipro follows similar math.

This explains why conservative investors bristle at Zomato commanding the same market cap as Wipro. The market has decided: Zomato represents the future, while Wipro represents maturity—or potential disruption. Wipro’s PE of 20-21x reflects its 5-6% free cash flow yield, not growth expectations.

Ironically, Wipro itself enjoyed “Zomato-like” valuations in 2001, when 90% of its value was terminal value.

Avenue Supermart (D-Mart) offers a sobering lesson in terminal value volatility. Until 2021’s tech IPO boom, D-Mart was the terminal value darling among Indian retailers.

The bull case was compelling: D-Mart was India’s Walmart-in-waiting, with 20-25 year growth forecasts assuming 30%+ annual expansion. This narrative pushed D-Mart to a median PE of 121x over seven years, with peaks at 150x.

Then quick commerce arrived. Suddenly, the market questioned whether D-Mart was the disruptor or the disrupted. The terminal value assumption that justified those astronomical multiples became suspect overnight.

Post-2021, terminal value investing has gone mainstream. New-age platforms (Swiggy, Zomato, Nykaa), electronics manufacturers (Dixon), retailers (Trent), and specialty manufacturers (Solar Industries) all trade at 100-150x PE multiples.

The common thread: Present value from their next 10 years of cash flows—even assuming 25% growth—accounts for less than 20% of their market valuations. Terminal value props up everything else.

Even seasoned investors struggle with this math. Motilal Oswal Private Equity sold their entire Dixon stake at IPO for under Rs 2,000 crore market cap, viewing it as a low-margin business with limited scale. Recently, they bought back just 2.77% for Rs 2,221 crore, effectively valuing Dixon at Rs 80,000+ crore.

The question: Were they wrong at IPO, or are they wrong now buying Dixon at 125x PE? Terminal value bets remain gambles—even for the professionals.

The Utpal Seth framework to approaching terminal value 

So can there be a formal framework for terminal value investing? Rakesh Jhunjhunwala was a master practitioner of it. Trust Mutual Fund, founded by Utpal Seth a close aide of RJ, is a recent entrant to the MF space and has said that it will follow the philosophy of “Terminal Value investing”. This may be the best place for investors to really understand how it works in practise. 

If you are keen to deep dive into this framework, you can  learn directly from Mr. Utpal Seth by listening to his 10 episode masterclass on terminal value investing  However, if you don’t have the time or patience, we have tried to summarise it below.

In its Terminal Value investing framework, Trust MF looks at companies through the prism of three key factors.

  1. Megatrends
  2. Leadership
  3. Intangibles

Each of these have significance and a combination of them is what creates Gorilla Companies.

If AI is a megatrend and a company with leadership in it owns proprietary technology (intangible) in this area, that is a Gorilla Company. We know that Nvidia ticks all the boxes.  Hyperscalers such as Amazon, Alphabet, Microsoft would also pop-up here.  A third line could be application developers, but as there may be many shareholder-value creation gets diluted leading to more monkeys than Gorillas in Mr Sheth’s view.

Illustration: Imagine that you bought a stock growing at 25% CAGR at a Price Earnings to Growth (PEG) ratio of 1 or 25 PE.

But a 25% growth stock deserves to trade at 50 times (PEG of 2) or more.

A 25% CAGR means one will double money in the stock every 3 Years, or 15 times in 12 Years if bought at 25PE. Even someone buying at a PEG of 2 (50PE) will make 15 times (25% CAGR) if PE still stays elevated for long. But buying at a PEG of 3 doesn’t result in meaningful returns.

Take another mega trend, Electric Vehicles or EVs. There is the pioneering EV behemoth in the US, Tesla, which exhibited scale, which has become a trillion-dollar company and set the benchmark for others. But it has an equally good Chinese rival now. You may have many more EV makers, battery makers, component makers, etc. beyond them in this mega trend, but the value creation gets diluted down the order.

Let’s now discuss how Trust MF identifies companies with high terminal value. 

The first and foremost thing is identifying Mega-trends, but it is also necessary to do it early. This is because stock markets unearth and discount trends very quickly.  By the time a trend is half-way through, valuations may already be sky-high. 

So what creates Mega-Trends? Technology changes, demand-supply imbalances, economic cycles and government policies give birth to Mega Trends.

A synonymous term used by billionaire investor, Ramdeo Agarwal of Motilal Oswal, is “Value Migration”, where growth and valuations completely shift from sector to another.

Identifying mega trends early helps us gain from both earnings growth and PE re-rating, leading to multi bagger returns.

Here are some specific mega trends with their causes. 

  • AI & EV: The obvious first order impact of the AI mega trend is on the $4 trillion M Cap NVIDIA, followed by hyperscalers (Amazon, Alphabet, Microsoft) and at the other end are application developers.

    When this is happening and Nasdaq is soaring to new highs, Indian IT services stocks are lagging fearing disruption. Their multiples today factor in cash flow yield and not growth. Likewise, the EV mega trend has led to creation of Tesla with a market-cap  never seen in the auto sector. With Chinese EV giant BYD and cell phone maker turned car maker Xiaomi becoming >$100 billion companies, the only legacy auto maker with large market cap  today is Toyota.
  • The digital consumption boom: A combination of mobile penetration, cheap data, technology and zero cost digital payment solutions have led to the rapid rise of technology-based platform businesses in India resulting in the Quick Commerce boom.

    Not only have these companies bowled out physical retailer’s growth story, they have also threatened the FMCG majors’ distribution moat. Q Comm stocks today enjoy far higher market cap than most FMCG names barring HUL and ITC. Zomato has also moved past D Mart in market value.
  • Defence and China +1: After three decades of peace, the world has seen heightened wars and conflicts in the last few years due to trade, currency and critical commodities triggering geopolitical conflicts. This is why the ignored defence sector has now come into the limelight globally.

    In a tight supply environment, India may need to make its own fighter jets. We could have a Gorilla in the making here if India’s only fighter jet maker can innovate at pace, come up with robust products and execute. History doesn’t suggest it, but the situation demands it and that’s when most surprises happen.

    Contract Research, Development and Manufacturing (CDMO) and Electronics Manufacturing Services (EMS) are emerging as two major China+1 opportunities where market is according significant terminal value at this point of time. As we write this, a pure play CDMO player has concluded a  3,400 Cr  offer for sale, at a valuation of Rs.32,000 crore for a company with revenues of Rs.1,800 crore.

Gorilla companies cannot be also-rans. They need to be leaders in a sector buoyed by a mega-trend.

In the AI mega trend, Nvidia is followed by  hyperscalers and application developers, but Nvidia has been the disproportionate value-creator.

In the EV mega trend, there is a Tesla with technology moat in software, but there is also a BYD with technology moat in battery manufacturing and even more. But electric vehicle manufacturers are many in number and just being an electric vehicle manufacturer may not lead to value creation. As Utpal Seth outs it, in any mega trend, there will be Gorillas and there will also be monkeys.

The leader may not be the first company to be listed in a space or the one with the largest market cap at a point of time. A leader should be capable of riding the mega trend through-out, maintaining leadership with a big lead.

As explained in the introduction, the peak market value of a stock in US has moved from $100bn in 2001 in the dot-com era to $4 trillion in today’s AI era. But intangibles were the key driver and not physical assets like plant or machinery or mines or oil fields.

A stand-out example of intangible assets is Pharma Patents. During the patent period, the pharma innovator makes a bounty and post patent, drug prices collapse 80-90% and still generic players make money. Other examples of intangibles include license, technology, brands, distribution, etc that have made several companies the Gorillas that we see today.

We have just heard Glenmark Pharma inking a deal with US pharma major AbbVie for licensing one of its molecules for an initial consideration of $700 million, final consideration of $1.22 billion and a double-digit royalty payment on commercialisation. Maybe one of the rare R&D outcomes in Indian pharma sector’s prosperous journey over the last 15-20 Years.

We have recently seen Bharat Forge and Solar Industries from non-glamorous businesses getting significant market attention for the kind of defence products they have come up with, an outcome of a decade of out-of-pocket R&D expenses. If there is one accounting number in which intangibles show up for investors, it is R&D expenditure as a % of the sales.

A caveat here. Gorilla companies need not always be new kids on the block.

Utpal Seth believes they can come from “adaptable incumbents” or “scalable challengers”.

If we look at financials, auto and consumer sectors, there are existing companies thriving in fintech or EV or digital disruption, which fit the description of “adaptable incumbents”.

Conclusion

What the terminal value investing philosophy unlocks is to look at companies from the lens of critical qualitative characteristics first and then get to numbers and valuations.

Starting with excel sheets is easy but getting carried away by them can lead to large, missed opportunities in the world of equities.

This is not a fool-proof investing philosophy though. Terminal Value investing, when you fail, can expose you to large downside. When your Gorilla bets fail, you can face the double-whammy collapsing growth expectations and price multiple compression. 

The key is disciplined execution. Successful terminal value investing demands constant vigilance—regularly stress-testing your mega-trend assumptions, monitoring competitive dynamics, and staying alert to early warning signs of disruption.

At PrimeInvestor, we integrate these terminal value principles into our stock recommendations, but with crucial guardrails. We don’t blindly chase tomorrow’s dreams at any price. Instead, we calculate terminal value scenarios to ensure our recommended entry points offer sufficient upside potential while building in margin of safety. More importantly, we continuously revisit these assumptions as industries evolve, competitive landscapes shift, and companies pivot their strategies.

This disciplined approach to terminal value analysis helps us identify genuine wealth creators while avoiding the trap of paying infinite prices for finite dreams. You can explore our carefully vetted recommendations in Prime Stocks, where we balance tomorrow’s potential with today’s prudence.

The securities quoted are for illustration purposes only and are not recommendatory.

More like this

3 thoughts on “Terminal Value investing: Finding Your Next Gorilla Stock”

  1. this is a interesting persepective, thank you for sharing . I have identified certain filters and ran across India and global markets. Revenue growth CAGR 3 years 25% or growing , PEG ratio 2 or less, ROE /ROCE last 3 years 15% or growing. Additionally added Rule of 40. Only handful of companies – Plantir , Eli Lilly , Waree and Laopu gold , Xiaomi, Shopify , BLS , MELI and Persistent qualify , In India companies like HAL etc doesn’t come up due to growth rate. Would be keen to hear your view if you where to translate this into a screening filters – what would your list looks like. I am happy to share the report and filters I had applied . Let me know

    1. N V Chandrachoodamani

      Welcome your query sir,

      Also delighted to know about the output of your screeners. Thanks for pointing the rule of 40, it’s a new learning to me and it actually looks interesting.

      HAL hasn’t come because of muted revenue growth, but PAT growth was far better than revenue growth. This can happen for Cos coming from a low growth business phase or a distressed economic environment (Eg, financials, cap goods, cement, steel, etc. Not just that any business coming out from low growth phase with margin expansion)

      EBIDTA to Operating cash flow conversion is other filter that can be applied to ensure that high growth is accompanied by adequate cash flow conversion and not just by blocking money in working capital (inventory/receivables).
      EBIDTA to OCF conversion rate of minimum of 65% can be applied

      So, incorporating PAT growth also as a filter apart from revenue growth can also refine it further

      In the end, if the asking PEG is more than 2, it makes sense to go for significant level of quality assurance (qualitative analysis) on each and every aspect – competitive positioning in business, management band-width, capital allocation decisions, etc

      Because, at high asking valuations, there is no margin of safety, and NOT going wrong on qualitative aspects is the only margin of safety

      That’s all to add for now. But feel free to come up with any further queries. Happy to dig into, refine and build queries that can facilitate better outcomes

      Thank you

      1. thankyou , glad you found rule of 40 useful. Originally I think it was applied for judging SAAS companies. Appreciate sharing – EBIDTA to OCF > 65% and PAT growth. Other metric I found useful is CFO/PAT ratio to identify quality of the earnings.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Hold On

You are being redirected to another page,
it may take a few seconds.
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

Start registration

OR
user icon
user icon
user icon

Terms & Conditions

A copy of the T&C has been sent to your email.

Last modified on February 18, 2025

This website www.primeinvestor.in (“Website”) is owned and operated by PrimeInvestor Financial Research Pvt. Ltd. (“RA”), a SEBI-registered Research Analyst with Registration No. INH200008653.

Through the Website, the RA allows clients to access research recommendations, research reports, and model portfolios, along with tools, personal finance products, and articles, on the payment of a subscription fee (“Research Services”). The terms ‘RA’ or ‘us’ or ‘we’ refer to PrimeInvestor Financial Research Pvt Ltd (SEBI RA Registration No INH200008653) who are the owners of this Website and offering the Research Services. The term ‘you’ and ‘client’ refers to the subscriber of the Services on the Website. The RA provides the Research Services subject to the notices, terms, and conditions set forth in these Terms. By accepting these Terms when you subscribe to the Research Services, you provide your consent to abide by these Terms.

Most Important Terms and Conditions (MITC)

[Forming part of the Terms and Conditions for providing research services]

  1. These terms and conditions, and consent thereon are for the research services provided by the Research Analyst (RA) and RA cannot execute/carry out any trade (purchase/sell transaction) on behalf of the client. Thus, the clients are advised not to permit RA to execute any trade on their behalf.
  2. The fee charged by RA to the client will be subject to the maximum amount prescribed by SEBI/ Research Analyst Administration and Supervisory Body (RAASB) from time to time (applicable only for Individual and HUF Clients).
    Note:
    • SEBI's current cap on fee is Rs 1,51,000/- per annum per family of client for all research services of the RA.
    • The fee limit does not include statutory charges.
    • The fee limits do not apply to a non-individual client / accredited investor.
  3. RA may charge fees in advance if agreed by the client. Such advance shall not exceed the period stipulated by SEBI; presently it is one quarter. In case of pre-mature termination of the RA services by either the client or the RA, the client shall be entitled to seek refund of proportionate fees only for the unexpired period.
  4. Fees to RA may be paid by the client through any of the specified modes like cheque, online bank transfer, UPI, etc. Cash payment is not allowed. Optionally the client can make payments through Centralized Fee Collection Mechanism (CeFCoM) managed by BSE Limited (i.e. currently recognized RAASB).
  5. The RA is required to abide by the applicable regulations/ circulars/ directions specified by SEBI and RAASB from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. The RA will endeavor to promptly inform the client of any conflict of interest that may affect the services being rendered to the client.
  6. Any assured/guaranteed/fixed returns schemes or any other schemes of similar nature are prohibited by law. No scheme of this nature shall be offered to the client by the RA.
  7. The RA cannot guarantee returns, profits, accuracy, or risk-free investments from the use of the RA's research services. All opinions, projections, estimates of the RA are based on the analysis of available data under certain assumptions as of the date of preparation/publication of research report.
  8. Any investment made based on recommendations in research reports are subject to market risks, and recommendations do not provide any assurance of returns. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report. Any reliance placed on the research report provided by the RA shall be as per the client's own judgement and assessment of the conclusions contained in the research report.
  9. The SEBI registration, Enlistment with RAASB, and NISM certification do not guarantee the performance of the RA or assure any returns to the client.
  10. For any grievances,
    • Step 1: the client should first contact the RA using the details on its website or following contact details:
      Customer care: [email protected]
      Grievance officer: [email protected], ATTN: Srikanth Meenakshi
      Compliance officer: [email protected], ATTN.: Bhavana Acharya
      Principal officer: [email protected], ATTN.: Vidya Bala
    • Step 2: If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at www.scores.sebi.gov.in
    • Step 3: The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal at https://smartodr.in
  11. Clients are required to keep contact details, including email id and mobile number/s updated with the RA at all times.
  12. The RA shall never ask for the client’s login credentials and OTPs for the client’s Trading Account, Demat Account, and Bank Account. Never share such information with anyone including RA.

By browsing, viewing, using the Website and subscribing to the Research Services provided therein you consent to and agree to comply with these Terms and Conditions of subscription (“Terms”).

The RA reserves the right to change or modify the Website, the contents thereof and these Terms at any time. All modifications to these Terms & Conditions will be posted on the Website and will become effective immediately upon such posting. Changes once made will be communicated to the client. Continued use of the Website shall be construed as acceptance of the revisions to the Terms by conduct.

The following terms and conditions include but are not limited to minimum mandatory terms and conditions to clients as stipulated by SEBI.

1. Availing the research services

By accepting delivery of the research service, the client confirms that he/she has elected to subscribe to the research service of the RA at his/her sole discretion. The RA confirms that Research Services shall be rendered in accordance with the applicable provisions of the SEBI RA Regulations.

2. Obligations on RA

The RA shall be bound by the SEBI Act and all the applicable rules and regulations of SEBI, including the RA Regulations and relevant notifications of Government, as may be in force, from time to time.

3. Client Information and KYC

The client shall furnish all such details in full as may be required by the RA in its standard form with supporting details, if required, as may be made mandatory by Research Analyst Administration and Supervisory Body(RAASB)/SEBI from time to time. RA shall collect, store, upload and check KYC records of the clients with KYC Registration Agency (KRA) as specified by SEBI from time to time.

4. Standard Terms of Service

The consent of client shall be taken on the following understanding:

“I / We have read and understood the terms and conditions applicable to a research analyst as defined under regulation 2(1)(u) of the SEBI (Research Analyst) Regulations, 2014, including the fee structure.

I/We are subscribing to the research services for our own benefits and consumption, and any reliance placed on the research report provided by research analyst shall be as per our own judgement and assessment of the conclusions contained in the research report.

I/We understand that –

  1. Any investment made based on the recommendations in the research report are subject to market risk.
  2. Recommendations in the research report do not provide any assurance of returns.
  3. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report.”

The declaration of the RA is as follows:

  1. We are duly registered with SEBI as an RA pursuant to the SEBI (Research Analysts) Regulations, 2014 and our registration details are: registration no SEBI INH200008653, with registration date 19th August, 2021
  2. We have the registration and qualifications required to render the services contemplated under the RA Regulations, and the same are valid and subsisting;
  3. Research analyst services provided by us do not conflict with or violate any provision of law, rule or regulation, contract, or other instrument to which it is a party or to which any of its property is or may be subject;
  4. The maximum fee that may be charged by the RA is ₹1.51 lakhs per annum per family of client. Our current fee structure, the term and duration of our subscription for our Research Services, can be viewed on our website here: https://primeinvestor.in/prime-pricing
  5. The recommendations provided by us as part of the Research Services do not provide any assurance of returns.

5. Consideration and mode of payment

The client shall duly pay to the RA the agreed fees for the services that RA renders to the client and statutory charges, as applicable. Such fees and statutory charges shall be payable through the specified manner and mode(s)/ mechanism(s).

The payment of fees shall be through a mode that shows traceability of funds. Such modes include but are not limited to credit cards/debit cards/ UPI/ net banking or any other mode specified by SEBI from time to time. However, the fees shall not be in cash.

6. Risk factors

  1. Investments are subject to market risk. Investing or trading in financial products involves risk. Past performance of the recommendation is not an indication of future returns. Past performance of the RA is not an indicator of future performance. Past performance of the security is not an indication of future returns.
  2. There are no assurances or guarantees that the objectives of any investment in financial products will be achieved.
  3. The names of financial products mentioned herein do not in any manner indicate their prospects or returns. The performance in the equity may be adversely affected by the performance of individual companies, changes in the market place and industry specific and macro-economic factors.
  4. The performance of the investments/ products recommended by the RA are subject to a wide range of risks, including but not limited to: performance of the respective companies, changes in equity and debt market conditions, micro and macro factors and forces affecting equity and debt markets, general levels of interest rates and interest rate risk, credit risk, liquidity risk, reinvestment risk, economic slowdown, volatility & illiquidity of the stocks, risks associated with trading volumes, liquidity and settlement systems in equity and debt markets and/or such other circumstance beyond the control of the RA or any of its Associates.
  5. Other risk factors include that may affect the performance of the investments/ products recommended by the RA include but are not limited to economic policies, changes of Government and its policies, acts of God, acts of war, civil disturbance, sovereign action and /or such other acts/ circumstance beyond the control of the RA or any of its Associates.
  6. The recommendations provided by the RA as part of its Research Services may not be suitable to all categories of investors.
  7. The client should read all scheme and security related documents carefully before investing.
  8. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

7. Conflict of interest

The RA shall adhere to the applicable regulations/ circulars/directions specified by SEBI from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

General disclosures: PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). PrimeInvestor Financial Research Pvt. Ltd., its employees, directors or agents, do not have any material adverse disciplinary history as on the date of publication of this report.

Restrictions on trading: To ensure no conflict of interest, the RA declares as follows:

  1. Personal trading activities of the individuals employed as research analysts shall be monitored, recorded and subject to a formal approval by the directors or compliance officer of PrimeInvestor Financial Research Private Limited.
  2. Research analysts employed by PrimeInvestor Financial Research Private Limited or their associates or relatives shall not:
    • Deal/ trade in stocks recommended/ tracked by the research analyst within 30 days before and five days after the publication of a research report;
    • Deal/ trade in securities that the research analyst reviews in a manner contrary to the given recommendation;
    • Purchase or receive securities of the issuer before the issuer's initial public offering, if the issuer is principally engaged in the same types of business as companies that the research analyst follows or recommends.

Disclosures with respect to Research and Recommendations Services:

  1. The RA or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation.
  2. The RA, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its Research Services or investment information.
  3. The Research Analysts who have prepared the research reports that form part of the Research Services (“Research Analyst”) certify that all of the views expressed in the research report accurately reflect their views about the subject company or subject security.
  4. The RA or directors or employees or Research Analyst certify that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
  5. The Research Analyst has not served as director, officer or employee in the subject company, AMC or insurance company of the mutual fund or insurance policy that is the subject of this report, or company whose bonds, NCDs, fixed deposits or other savings products that is the subject of this report.
  6. The Research Analyst or their relatives do not have any known direct or indirect material conflict of interest including long/short positions in the subject company.
  7. The Research Analyst may hold investments in the stocks, mutual fund schemes, bonds, fixed deposits, insurance policies, or other products that are the subject of the recommendations provided as part of the Research Services. The Research Analyst certifies that they will not act in a manner contrary to their views on these securities except in the event of significant news or event or change in personal financial circumstances and without formal approval from the directors of PrimeInvestor Financial Research Pvt. Ltd. or the compliance officer.
  8. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of the Research Services. Such conflict of interest shall be disclosed to the client as and when they arise.
  9. The RA or its directors or its employee or its associates have not managed or co-managed the public offering of any company. The RA or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. The RA or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. The RA or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation.
  10. The subject company of its research recommendations was not a client of the RA or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided.
  11. The RA or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.

PrimeInvestor Financial Research Pvt. Ltd., its Associates, the Research Analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies)? – NO

8. Termination of service and refund of fees:

The RA may terminate or suspend rendering of Research Services to the client in the following circumstances:

  1. On account of suspension/cancellation of registration of RA by SEBI. In case of suspension of certificate of registration of the RA for more than 60 (sixty) days or cancellation of the RA registration, RA shall refund the fees, on a pro rata basis for the period from the effective date of cancellation/ suspension to end of the client’s subscription period.
  2. The RA voluntarily chooses to terminate its Research Service. In the event of such termination of the Research Service, the RA shall refund the fees, on a pro rata basis for the period from the date of such termination of research service to end of the client’s subscription period.

9. Grievance redressal and dispute resolution:

Any grievance related to:

  1. nonreceipt of research report, or
  2. missing pages or inability to download the entire report, or
  3. any other deficiency in the research services provided by RA

shall be escalated promptly by the client to the person/employee designated by RA, in this behalf as under:

Name: Bhavana Acharya
Designation: Director & Compliance Officer, PrimeInvestor Financial Research Pvt Ltd
Email: [email protected]

The RA shall be responsible to resolve grievances within 7 (seven) business working days or such timelines as may be specified by SEBI under the RA Regulations.

RA shall redress grievances of the client in a timely and transparent manner. Any dispute between the RA and his client may be resolved through arbitration or through any other modes or mechanism as specified by SEBI from time to time.

If the client is not satisfied with the response of the RA, he/she can lodge his/her grievances with SEBI at scores.sebi.gov.in. Alternatively, the client may also write to any of the offices of SEBI. For any queries, feedback or assistance, please contact SEBI Office on Toll Free Helpline at 1800 22 7575 / 1800 266 7575

Details on grievances are available on the Website as follows: https://primeinvestor.in/ra-grievance/

10. Additional clauses:

Scope of the Research Service: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Services are not meant to be tailor-made or customized solutions that specifically apply to each client based on his/her risk profile.

The RA never guarantees the returns on the recommendation provided. Investor shall take note that investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The RA shall not be responsible for any loss to the Investors.

This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.

The Research Service, including recommendations, research reports, updates, and other information will be accessible through the RA’s website https://primeinvestor.in only. Such recommendations and updates will not be provided over phone calls.

Fees: Our current fee structure, the term and duration of our subscription for our Research Service, can be viewed on our website: https://primeinvestor.in/prime-pricing. Eligibility for any discounts is ascertained at the time the client subscribes. Any such discount and its tenure shall be at the discretion of the RA.

Subscription and access to content services fall under the purview of Goods and Services Tax (GST) as per the current indirect taxation policy, Government of India. Unless otherwise indicated, prices stated on our website are exclusive of applicable GST, any applicable value added tax (VAT) or other sales taxes. We are a business-to-consumer (B2C) service provider and we do not commit to provide any input tax credit on GST charged on subscription to our Research Service.

We may change the Subscription Fees and charges then in effect, or add new fees or charges which will take effect at the end of the client’s subscription period, by giving notice in advance and an opportunity to cancel renewal of the subscription.

Subscription Access & Renewal: Subscription to the Website commences immediately on the realisation of payment of the Subscription Fees. Subscriptions are set to be renewed automatically at the end of the subscription period.

Unless the client notifies us before the end of his/her subscription period, or the client cancels the auto-renewal mandate within the period specified by law, that the client does not wish to renew his/her subscription, the client’s subscription will renew for the period defined by the client’s subscription plan. We will charge the subscription using the same payment method that you previously used.

Although the client may notify to us his/her intention to his/her subscription, such notice will only take effect at the end of his/her then current subscription period, and he/she will not receive a refund other than as set out under Clause 8 in these Terms.

The client may notify us of his/her wish to cancel his/her subscription by sending an email to [email protected]. The client must provide at least 5 business days advance notice for this to be implemented.

Refunds: There can be no cancellation and refund of subscription fee paid once the subscription is active, other than as stated in Clause 8 of these Terms. If the client is entitled to a refund as specified under Clause 8 of these Terms, the RA will credit that refund to the card or other payment method used by the client to submit payment, unless it has expired - in which case the RA will contact the client to proceed with the refund. If we do issue a refund or credit due to circumstances outside the obligations specified under Clause 8, we are under no obligation to issue the same or a similar refund in the future.

General disclaimers: The recommendations made herein in the Research Services are expression of views and/or opinions and should not be deemed or construed to be advice for the purpose of purchase or sale of any security, nor a solicitation or offering on any investment/ trading opportunity on behalf of the company, AMC, insurance company, or issuer of security referred to herein.

The content and research reports generated by the RA does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities.

The information/ opinion/ views mentioned in research reports or by the RA are not meant to serve as a professional guide to the client or recipients of this Report. The research report, recommendation, or any other content published by the RA do not assure or guarantee any minimum or fixed returns to the client or recipients of the reports/ recommendations/ content.

Use of this information is at the client’s own risk. The client must make his/ her own investment decisions based on his/her specific investment objective and financial position and using such independent advisors as he/she believes necessary. The services rendered by the RA are on a best-effort basis. All information in the content or research report of the RA is provided on an as is basis. Information is believed to be reliable but the RA does not warrant its completeness or accuracy and expressly disclaim all warranties and conditions of any kind, whether express or implied.

While due care has been taken to ensure that the disclosures, information, and opinions given are fair and reasonable, PrimeInvestor Financial Research Pvt Ltd and/or none of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information/ opinions/ views contained in the research report and recommendations that form part of the Research Service, and/or mails, social media or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

Any agreements, transactions or other arrangements made between the client and any third party named on (or linked to from) the Website are at your own responsibility and entered into at your own risk. Any information that you receive via the Website, whether or not it is classified as “real time”, may have stopped being current by the time it reaches you. Market price information may be rounded up/down and therefore may not be entirely accurate.

The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research Services before onboarding.

History, present business and background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services.

Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made thereunder against the Research Analyst relating to Research Analyst services.

Details of the RA's associates: No associates.

Usage of Website Content: This Website is controlled and operated by the RA. All material, including research reports, recommendations, portfolios, ratings, lists of financial products, illustrations, statements, opinions, views, photographs, products, images, artwork, designs, text, graphics, logos, button icons, images, audio and video clips and software (collectively, “Content”) are protected by copyrights, trademarks and other intellectual property rights that are owned and controlled by the RA or by other parties that have licensed their material to us.

Except where otherwise agreed in writing with the RA, material on the Website is solely for the client’s personal, non-commercial use. Except as provided below, the client must not copy, reproduce, republish, upload, post, transmit or distribute such material in any way, including by e-mail or other electronic means and whether directly or indirectly and the client must not assist any other person to do so.

Without the prior written consent of the RA, modification of the materials, use of the materials on any other web site or networked computer environment or use of the materials for any purpose other than personal, non-commercial use is a violation of the copyrights, trademarks and other proprietary rights, and is prohibited. Any use for which the client receives any remuneration, whether in money or otherwise, is a commercial use for the purposes of these Terms.

The client may occasionally distribute a copy of a research report, or a portion of the same, from the Website in non-electronic form to a few individuals without charge, provided the client includes all copyright and other proprietary rights notices in the same form in which the notices appear, original source attribution, and the phrase “Used with permission from PrimeInvestor Financial Research Pvt. Ltd.”

While the client may occasionally download and store research reports or information from the Website for his/her personal use, he/she may not otherwise provide others with access to the same. The foregoing does not apply to any sharing functionality we provide through the Website that expressly allows the client to share Content or links to Content with others. In addition, the client may not use Content he/she has downloaded for personal use to develop or operate an automated trading system or for data or text mining.

The client agrees not to rearrange or modify the Content available through the Website. The client agrees not to display, post, frame, or scrape the Content for use on another website, app, blog, product or service, except as otherwise expressly permitted by these Terms. You agree not to create any derivative work based on or containing the research products and Content. The framing or scraping of or in-line linking to the Services or any Content contained thereon and/or the use of webcrawler, spidering or other automated means to access, copy, index, process and/or store any Content made available on or through the Services other than as expressly authorized by us is prohibited.

The client further agrees to abide by exclusionary protocols (e.g., Robots.txt, Automated Content Access Protocol (ACAP), etc.) that may be used in connection with the Research Services. The client may not access parts of the Research Services to which he/she is not authorized, or attempt to circumvent any restrictions imposed on your use or access of the Services.

As a general rule, the client may not use the Content, including without limitation, any Content made available through one of our RSS Feeds, in any commercial product or service, without our express written consent.

The client may not create apps, extensions, or other products and services that use our Content without our permission. The client may not aggregate or otherwise use our Content in a manner that could reasonably serve as a substitute for a subscription to the Website.

The client may not access or view the Services with the use of any scripts, extensions, or programs that alter the way the Services are displayed, rendered, or transmitted to you without our written consent.

The client agrees not to use the Services for any unlawful purpose. We reserve the right to terminate or restrict the client's access to the Website if, in our opinion, the client's use of the Services may violate any laws, regulations or rulings, infringe upon another person's rights or violate these Terms.

Prohibited content: The Website includes comments sections, blogs and other interactive features that allow interaction among clients and between clients and the RA. We call the information posted by or contributed by users “Contributed Content.” In the course of availing of the Research Services or uploading any post or comment on the Website, the client shall not post any Contributed Content that (i) contains nude, semi-nude, sexually suggestive photos, (ii) tends or is likely to abuse, harass, threaten, impersonate or intimidate other users of the Website and/or Research Services, (iii) is lascivious or appeals to the prurient interest or if its effect is such as to tend to deprave and corrupt persons who are likely to use or have access to the Website and/or Services, or (iv) otherwise violates, is prohibited or restricted by applicable law, rule or regulation, is offensive or illegal or violates the rights of, harms or threatens the safety of other users of the Website and/or Services (collectively “Prohibited Content”).

We reserve the right to cease to provide the client with the Research Services or access to the Website, or terminate your subscription, with immediate effect and without notice and liability, for violating these Terms, applicable law, rules or regulations and reserves the right to remove Prohibited Content which is in violation of these Terms, or is otherwise abusive, illegal or disruptive. The determination of whether any content constitutes Prohibited Content, violates these Terms, or is otherwise abusive illegal or disruptive, is subject to the sole determination of the Firm.

Changes to Research Services: We are constantly endeavouring to improve the quality of Research Services provided to our clients. Due to this, the form and nature of the Research Services provided may change from time to time without any prior notice to the client. We reserve the right to introduce and initiate new features, functionalities, components to the Website and/or Research Services and/or change, alter, modify, or discontinue existing ones without any prior notice to the client.

Warranty and liability disclaimer: The Website, Research Services, and all the materials and services, included on or otherwise made available to the client through this Website is provided by the RA on an “as is” and “as available” basis without any representation or warranties, express or implied except otherwise specified in writing. Without prejudice to the foregoing paragraph, the RA does not warrant that:

  • This Website and/or Research Services will be constantly available, or available at all;
  • The information on this Website or provided through the Research Services is complete, true, accurate or not misleading; or
  • The quality of any products, services, information, or other material that you obtain through the Website or Services will meet your expectations.

The RA, to the fullest extent permitted by law, disclaims all warranties, whether express or implied, including the warranty of merchantability, fitness for particular purpose and non-infringement. The RA makes no warranties about the accuracy, reliability, completeness, or timeliness of the Website, Research Services, Content, Contributed Content, Services, software, text, graphics and links.

The RA does not warrant that this Website, Research Services, information, content, materials, or any other material included on or otherwise made available to you through this Website, their servers, or electronic communication sent by the RA are free of viruses or other harmful components.

Nothing on this Website constitutes, or is meant to constitute, advice of any kind.

Indemnification: The client:

  1. Represents, warrants and covenants that no materials of any kind provided by him/her will:
    1. Violate, plagiarise, or infringe upon the rights of any third party, including copyright, trademark, privacy or other personal or proprietary rights; or
    2. Contain libellous, Prohibited Content or other unlawful material;
  2. Hereby agree to indemnify, defend and hold harmless the RA and all of the RA’s officers, directors, owners, agents, customers/clients, information providers, affiliates, licensors and licensees (collectively, the “Indemnified Parties”) from and against any and all liability and costs, including, without limitation, reasonable advocate’s fees, incurred by the Indemnified Parties in connection with any claim arising out of any breach by the client of these Terms or the foregoing representations, warranties and covenants. The client shall cooperate as fully as reasonably required in the defence of any such claim. The RA reserves the right, at its own expense, to assume the exclusive defence and control of any matter subject to indemnification by the client.

Applicable law: This Website, including the Content and Contributed Content and information contained herein, and the provision of Research Services shall be governed by the Securities and Exchange Board of India, laws of the Republic of India and the courts of Chennai, India which shall retain exclusive jurisdiction to entertain any proceedings in relation to any disputes arising out of the same. As such, the laws of India shall govern any transaction completed using this Website.

Information gathered and tracked: Information submitted or collected on the Website or pursuant to the use of the Services is stored in a database. Specifically, we store the username, name, e-mail address, contact number, as submitted or collected on our Website or through the provision of the Research Services. We may use such information to send out occasional promotional materials, including alerts on new Services available, or other promotional and marketing material relating to our clients and customers.

In accordance with the Information Technology Act 2000, the name and the details of the Grievance Officer at PrimeInvestor is provided below:

Mr. Srikanth Meenakshi
PrimeInvestor Financial Research Pvt. Ltd., Registered office: 659, 4th Avenue, D-Sector, Anna Nagar Western Extension, Chennai 600 101.
Email: [email protected]

11. Mandatory notice:

Clients shall be requested to go through Do’s and Don’ts while dealing with RA as specified in SEBI master circular no. SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024 or as may be specified by SEBI from time to time.

12. Optional Centralised Fee Collection Mechanism:

SEBI has operationalized a centralized fee collection mechanism for IA and RA. Under this mechanism, clients shall pay fees to IAs/RAs through a designated platform/portal administered by a recognized Administration and Supervision body. This is an optional mechanism for the registered entities. At this time, PrimeInvestor has opted out of this fee collection mechanism. Therefore, all subscription payments for the Research Services will be through the modes as specified in Clause 5 of these Terms.

Enter the OTP sent to (Edit)
By doing this you agree to our terms & conditions
Didn't receive OTP? Resend

comHi,

Registration Sucessful

Your 7-day Free Trial has started


comVerify your KYC

Unlock coupon 10% discount code

user icon
user icon
user icon
Skip for now

comHi,

Registration Sucessful

Your 7-day Free Trial has started


comKYC Verified

Discount Unlocked

com

*Applicable only on our Annual Subscription plans

Coupon will be auto applied during checkout

Skip for now
Have an account?
Login To Your Account
OR
Don’t have an account ? Register for free